Skip to content

Clinical trials

Completed Lung Diseases, Interstitial trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases, Interstitial Status: Completed Country / region: Netherlands Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20081
20142
20151
20173
20223

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim2
Maastricht University2
Maastricht University Medical Center2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Hoffmann-La Roche1
Human Adams1
Radboud University Medical Center1
United Therapeutics1
aTyr Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases, Interstitial12
Idiopathic Pulmonary Fibrosis5
Inflammation3
Sarcoidosis3
Fibrosis2
Breast Neoplasms1
Granuloma1
Lymphoproliferative Disorders1
Pneumonia1
Pulmonary Disease, Chronic Obstructive1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.